Fortress Biotech, Inc. / Fundamentals
Income statement
- Net revenue
€50.88M - Cost of goods sold
€14.80M - Gross profit
€36.08M - SG&A expenses
€97.19M - R&D expenses
€26.98M - EBITDA
-€60.57M - D&A
€5.83M - EBIT
-€89.85M - Interest expenses
€12.12M - EBT
-€76.32M - Tax expenses
€347.49K - Net income
-€12.64M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€18.59M - Changes in working capital
-€14.91M - Operating cash flow
-€68.72M - Capex
€0.00 - Other investing cash flow
-€6.65M - Net investing cash flow
-€6.65M - Total cash dividends paid
-€578.29K - Issuance of common stock
€44.64M - Debt repayment
-€15.35M - Other financing cash flow
€43.83M - Net financing cash flow
€73.08M - Foreign exchange effects
€0.00 - Net change in cash
-€2.28M - Cash at end of period
€64.87M - Free cash flow
-€68.72M
Balance sheet
- Cash and cash equivalents
€63.82M - Cash and short-term investments
€63.82M - Total receivables
€13.90M - Inventory
€11.03M - Other current assets
€5.97M - Total current assets
€94.72M - Property, plant & equipment
€13.32M - Goodwill
€0.00 - Intangible assets
€25.51M - Long-term investments
€1.05M - Other non-current assets
€2.59M - Total non-current assets
€42.47M - Total assets
€137.19M - Accounts payable
€17.32M - Short-term debt
€5.05M - Other current liabilities
€26.13M - Total current liabilities
€49.35M - Long-term debt
€54.34M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€1.43M - Total non-current liabilities
€55.76M - Total liabilities
€105.12M - Common stock
€25.74K - Retained earnings
-€631.46M - Other equity
€0.00 - Total equity
€32.07M - Total liabilities and shareholders' equity
€137.19M
Company information
- Market capitalization
€45.90M - Employees
101 - Enterprise Value
€44.99M
Company ratios
- Gross margin
-
70.9% Much better than peer group: -5,318.6% - EBITDA margin
-
-119.0% Much better than peer group: -25,005.6% - EBIT margin
-
-176.6% Much better than peer group: -25,754.3% - EBT margin
-
-150.0% Much better than peer group: -49,974.1% - Net margin
-
-24.8% Much better than peer group: -26,769.8% - ROE
-
-39.4% Much better than peer group: -117.6% - ROA
-
-9.2% Much better than peer group: -89.0% - Asset turnover
-
37.1% Much better than peer group: 9.3% - FCF margin
-
-135.1% Much better than peer group: -24,091.3% - FCF yield
-149.7% - Efficiency ratio
219.0% - Net sales per employee
-
€503.77K - Net income per employee
-
-€125.13K